<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-747</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАБЛЮДЕНИЯ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Благоприятный исход беременности у пациентки с морбидным ожирением, сахарным диабетом 2 типа и экстремально высокой исходной протеинурией</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3603-8524</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прокопенко</surname><given-names>Елена Ивановна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор кафедры трансплантологии, нефрологии и искусственных органов ФУВ ГБУЗ МО МОНИКИ им. М.Ф. Владимирского; ст. науч. сотр. хирургического отделения трансплантации почки ГБУЗ МО МОНИКИ им. М.Ф. Владимирского;  нефролог отделения антенатальной охраны плода и здоровья женщин ГБУЗ МО МОНИИАГ им. академика В.И. Краснопольского</p></bio><email xlink:type="simple">renalnephron@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9943-0964</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурумкулова</surname><given-names>Фатима Фархадовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, вед. науч. сотр. терапевтической группы ГБУЗ МО МОНИИАГ им. академика В.И. Краснопольского; профессор кафедры акушерства и гинекологии ФУВ ГБУЗ МО МОНИКИ им. М.Ф. Владимирского</p></bio><email xlink:type="simple">fatima-burumkulova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8995-6727</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коваленко</surname><given-names>Татьяна Станиславовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, вед. науч. сотр. акушерского физиологического отделения ГБУЗ МО МОНИИАГ им. академика В.И. Краснопольского</p></bio><email xlink:type="simple">zurik2668@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8497-0693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ватазин</surname><given-names>Андрей Владимирович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, зав. кафедрой трансплантологии, нефрологии и искусственных органов ФУВ ГБУЗ МО МОНИКИ им. М.Ф. Владимирского; гл. науч. сотр. хирургического отделения трансплантации почки ГБУЗ МО МОНИКИ им. М.Ф. Владимирского</p></bio><email xlink:type="simple">vatazin@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»&#13;
ГБУЗ МО Московский областной научно-исследовательский институт акушерства и гинекологии  им. академика В.И. Краснопольского</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ГБУЗ МО Московский областной научно-исследовательский институт акушерства и гинекологии  им. академика В.И. Краснопольского</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2025</year></pub-date><volume>27</volume><issue>1</issue><elocation-id>747</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Прокопенко Е.И., Бурумкулова Ф.Ф., Коваленко Т.С., Ватазин А.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Прокопенко Е.И., Бурумкулова Ф.Ф., Коваленко Т.С., Ватазин А.В.</copyright-holder><copyright-holder xml:lang="en">Прокопенко Е.И., Бурумкулова Ф.Ф., Коваленко Т.С., Ватазин А.В.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/747">https://journal.nephro.ru/jour/article/view/747</self-uri><abstract><p>Распространенность сахарного диабета 2 типа (СД2) и ожирения у беременных возрастает, особенно в позднем репродуктивном возрасте. СД2, артериальная гипертония (АГ), протеинурия, снижение почечной функции повышают частоту осложнений беременности –преэклампсии (ПЭ), преждевременных родов, необходимости кесарева сечения (КС), врожденных пороков развития, дыхательных, метаболических нарушений у новорожденных, перинатальной смертности, ускоренного прогрессирования хронической болезни почек у матерей.</p><p>В статье описано наблюдение незапланированной беременности у женщины 45 лет с морбидным ожирением (ИМТ 50,39), АГ, СД2, крайней высокой протеинурией (12 г/сут), прегестационным креатинином сыворотки 210 мкмоль/л. От прерывания беременности по медицинским показаниям пациентка отказалась. Была проведена коррекция сахароснижающей терапии – назначены инсулины детемир и аспарт, достигнут целевой уровень HbA1C – ниже 6%. Для профилактики ПЭ и тромбоэмболических осложнений использовались ацетилсалициловая кислота 150 мг/сут и эноксапарин по 0,4 мл 2 раза в день. Неоднократно проводилась коррекция антигипертензивной терапии по результатам суточного мониторирования АД: с 26 недель пациентка получала метилдопа, нифедипин продленного действия и бисопролол. ПЭ, задержки роста плода не отмечено. При сроке беременности 36 недель 4 дня произведено плановое КС в связи с тазовым предлежанием. Родилась девочка с признаками диабетической фетопатии массой 3290 г, длиной 51 см, оценка по шкале Апгар – 7/8 баллов. Послеродовый период протекал без осложнений, мать и ребенок выписаны домой на 8-е сутки после родов.  </p><p>Девочка здорова, развивается в соответствии с возрастом. После родов матери была назначена нефропротективная терапия, однако через 6 мес. пациентка самостоятельно прекратила наблюдение. Известно, что через 1,5 года после родов был начат программный гемодиализ. Благоприятный акушерский исход достигнут за счет мультидисциплинарного наблюдения, профилактики осложнений, строгой коррекции гликемии и АД.</p></abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>сахарный диабет 2 типа</kwd><kwd>ожирение</kwd><kwd>хроническая болезнь почек</kwd><kwd>высокая протеинурия</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Coton S.J., Nazareth I., Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open 2016;6: e009494. doi:10.1136/bmjopen-2015009494</mixed-citation><mixed-citation xml:lang="en">Coton S.J., Nazareth I., Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open 2016;6: e009494. doi:10.1136/bmjopen-2015009494</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ngwezi D.P., Savu A., Yeung R.O. et al. Temporal trends in type 1, type 2, and gestational diabetes in pregnancy: impact of rural residence, ethnicity, and material deprivation. Can J Diabetes. 2023 Dec;47(8):672-679.e3. doi: 10.1016/j.jcjd.2023.07.007</mixed-citation><mixed-citation xml:lang="en">Ngwezi D.P., Savu A., Yeung R.O. et al. Temporal trends in type 1, type 2, and gestational diabetes in pregnancy: impact of rural residence, ethnicity, and material deprivation. Can J Diabetes. 2023 Dec;47(8):672-679.e3. doi: 10.1016/j.jcjd.2023.07.007</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Raets L., Ingelbrecht A., Benhalima K. Management of type 2 diabetes in pregnancy: a narrative review. Front Endocrinol (Lausanne). 2023:14:1193271. doi: 10.3389/fendo.2023.1193271</mixed-citation><mixed-citation xml:lang="en">Raets L., Ingelbrecht A., Benhalima K. Management of type 2 diabetes in pregnancy: a narrative review. Front Endocrinol (Lausanne). 2023:14:1193271. doi: 10.3389/fendo.2023.1193271</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association Professional Practice Committee. Management of diabetes in pregnancy: standards of care in diabetes – 2024. Diabetes Care 2024;47(Supplement_1): S282–S29. doi:10.2337/dc24-S015</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association Professional Practice Committee. Management of diabetes in pregnancy: standards of care in diabetes – 2024. Diabetes Care 2024;47(Supplement_1): S282–S29. doi:10.2337/dc24-S015</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Clement N.S., Abul A., Farrelly R. et al. Pregnancy Outcomes in Type 2 Diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024: S0002-9378(24)01176-1. doi: 10.1016/j.ajog.2024.11.026</mixed-citation><mixed-citation xml:lang="en">Clement N.S., Abul A., Farrelly R. et al. Pregnancy Outcomes in Type 2 Diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024: S0002-9378(24)01176-1. doi: 10.1016/j.ajog.2024.11.026</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Drabløs M., Risstad H., Alnæs-Katjavivi P., Qvigstad E. Pregnancy outcomes in type 2 versus type 1 diabetes: systematic review with meta-analyses. Endocr Connect. 2024 25;13(12):e240066. doi: 10.1530/EC-24-0066</mixed-citation><mixed-citation xml:lang="en">Drabløs M., Risstad H., Alnæs-Katjavivi P., Qvigstad E. Pregnancy outcomes in type 2 versus type 1 diabetes: systematic review with meta-analyses. Endocr Connect. 2024 25;13(12):e240066. doi: 10.1530/EC-24-0066</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li S., Ma S., Yao X., Liu P. Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome. J Endocr Soc. 2024;8(10):bvae143. doi: 10.1210/jendso/bvae143</mixed-citation><mixed-citation xml:lang="en">Li S., Ma S., Yao X., Liu P. Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome. J Endocr Soc. 2024;8(10):bvae143. doi: 10.1210/jendso/bvae143</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yang S.T., Liu C.H., Ma S.H. et al. Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Jul 26;19(15):9094. doi: 10.3390/ijerph19159094</mixed-citation><mixed-citation xml:lang="en">Yang S.T., Liu C.H., Ma S.H. et al. Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Jul 26;19(15):9094. doi: 10.3390/ijerph19159094</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M., Liu X., Liu X. et al. Association of pre-/early pregnancy high blood pressure and pregnancy outcomes: a systemic review and meta-analysis. J Matern Fetal Neonatal Med. 2024 Dec;37(1):2296366. doi: 10.1080/14767058.2023.2296366</mixed-citation><mixed-citation xml:lang="en">Jin M., Liu X., Liu X. et al. Association of pre-/early pregnancy high blood pressure and pregnancy outcomes: a systemic review and meta-analysis. J Matern Fetal Neonatal Med. 2024 Dec;37(1):2296366. doi: 10.1080/14767058.2023.2296366</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Relph S., Patel T., Delaney L. et al. Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis. PLoS Med. 2021 Nov 22;18(11):e1003856. doi: 10.1371/journal.pmed.1003856</mixed-citation><mixed-citation xml:lang="en">Relph S., Patel T., Delaney L. et al. Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis. PLoS Med. 2021 Nov 22;18(11):e1003856. doi: 10.1371/journal.pmed.1003856</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gleeson S., Svetitsky S., Frise C. Diabetic kidney disease and pregnancy outcomes: a systematic review. Brit J Diab. 2021; 21 (2): 175-185. doi: 10.15277/bjd.2021.306</mixed-citation><mixed-citation xml:lang="en">Gleeson S., Svetitsky S., Frise C. Diabetic kidney disease and pregnancy outcomes: a systematic review. Brit J Diab. 2021; 21 (2): 175-185. doi: 10.15277/bjd.2021.306</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Российское общество акушеров-гинекологов. Клинические рекомендации «Нормальная беременность». 2023. https://cr.minzdrav.gov.ru/preview-cr/288_2</mixed-citation><mixed-citation xml:lang="en">Russian Society of Obstetricians and Gynecologists. Clinical guidelines «Normal pregnancy». 2023. https://cr.minzdrav.gov.ru/preview-cr/288_2</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Russian Society of Obstetricians and Gynecologists. Clinical guidelines «Normal pregnancy». 2023. https://cr.minzdrav.gov.ru/preview-cr/288_2</mixed-citation><mixed-citation xml:lang="en">Henderson J.T., Whitlock E.P., O’Connor E. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(10):695-703. doi: 10.7326/M13-2844</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Henderson J.T., Whitlock E.P., O’Connor E. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(10):695-703. doi: 10.7326/M13-2844</mixed-citation><mixed-citation xml:lang="en">Russian Society of Obstetricians and Gynecologists. Clinical guidelines «Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period». . 2024. https://cr.minzdrav.gov.ru/preview-cr/637_2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Российское общество акушеров-гинекологов. Клинические рекомендации «Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде». 2024. https://cr.minzdrav.gov.ru/preview-cr/637_2</mixed-citation><mixed-citation xml:lang="en">Piccoli G.B., Cabiddu G., Attini R. et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015 Aug;26(8):2011-22. doi: 10.1681/ASN.2014050459</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Russian Society of Obstetricians and Gynecologists. Clinical guidelines «Preeclampsia. Eclampsia. Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period». . 2024. https://cr.minzdrav.gov.ru/preview-cr/637_2</mixed-citation><mixed-citation xml:lang="en">Yuan F., Li Z., Chen S. et al. Risk prediction for preeclampsia in CKD patients: development of a model in a retrospective cohort. J Nephrol. 2024 Dec;37(9):2499-2508. doi: 10.1007/s40620-024-02010-w</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Piccoli G.B., Cabiddu G., Attini R. et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015 Aug;26(8):2011-22. doi: 10.1681/ASN.2014050459</mixed-citation><mixed-citation xml:lang="en">Prokopenko E.I., Nikolskaya I.G., Gubina D.V. Pregnancy in women with primary chronic glomerulonephritis in the era of prevention of placenta-associated complications. A review and analysis of outcomes of 120 pregnancies in one center. Nephrology and Dialysis. 2021; 23(4): 526-538. doi: 10.28996/2618-9801-2021-4-526-538</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan F., Li Z., Chen S. et al. Risk prediction for preeclampsia in CKD patients: development of a model in a retrospective cohort. J Nephrol. 2024 Dec;37(9):2499-2508. doi: 10.1007/s40620-024-02010-w</mixed-citation><mixed-citation xml:lang="en">Koirala P., Garovic V., Irene Dato M., Kattah A. Role of chronic kidney disease and risk factors in preeclampsia. Pregnancy Hypertens. 2024 Sep; 37:101146. doi: 10.1016/j.preghy.2024.101146</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Прокопенко Е.И., Никольская И.Г., Губина Д.В. Беременность у пациенток с первичным хроническим гломерулонефритом в эру профилактики ассоциированных с плацентой осложнений. Обзор литературы и анализ исходов 120 беременностей в одном центре. Нефрология и диализ. 2021; 23(4): 526-538. doi: 10.28996/2618-9801-2021-4-526-538</mixed-citation><mixed-citation xml:lang="en">Bertagnolli M. Mitigating preeclampsia risk through effective uncontrolled blood pressure management. Hypertens Res. 2024;47(2):545-547. doi: 10.1038/s41440-023-01489-3</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Prokopenko E.I., Nikolskaya I.G., Gubina D.V. Pregnancy in women with primary chronic glomerulonephritis in the era of prevention of placenta-associated complications. A review and analysis of outcomes of 120 pregnancies in one center. Nephrology and Dialysis. 2021; 23(4): 526-538. doi: 10.28996/2618-9801-2021-4-526-538</mixed-citation><mixed-citation xml:lang="en">Salazar M.R., Espeche W.G., Minetto J. et al. Uncontrolled and masked uncontrolled blood pressure in treated pregnant women with chronic hypertension and risk for preeclampsia/eclampsia. Hypertens Res. 2023 Dec;46(12):2729-2737. doi: 10.1038/s41440-023-01443-3</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Koirala P., Garovic V., Irene Dato M., Kattah A. Role of chronic kidney disease and risk factors in preeclampsia. Pregnancy Hypertens. 2024 Sep; 37:101146. doi: 10.1016/j.preghy.2024.101146</mixed-citation><mixed-citation xml:lang="en">Lauszus F.F., Rasmussen O.W., Lousen T. et al. Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Acta Obstet Gynecol Scand. 2001 Dec;80(12):1096-103. doi: 10.1034/j.1600-0412.2001.801204.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bertagnolli M. Mitigating preeclampsia risk through effective uncontrolled blood pressure management. Hypertens Res. 2024;47(2):545-547. doi: 10.1038/s41440-023-01489-3</mixed-citation><mixed-citation xml:lang="en">Nørgaard S.K., Vestgaard M.J., Jørgensen I.L. et al. Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes. Diabetes Res Clin Pract. 2018 Apr:138:229-237. doi: 10.1016/j.diabres.2018.02.014</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Salazar M.R., Espeche W.G., Minetto J. et al. Uncontrolled and masked uncontrolled blood pressure in treated pregnant women with chronic hypertension and risk for preeclampsia/eclampsia. Hypertens Res. 2023 Dec;46(12):2729-2737. doi: 10.1038/s41440-023-01443-3</mixed-citation><mixed-citation xml:lang="en">Demyanova K.A., Kozlovskaya N.L., Korotchaeva Yu.V. et al. Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease. Ter Arch. 2021; 93(6): 53-59. 685-692. doi: 10.26442/00403660.2021.06.200867</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lauszus F.F., Rasmussen O.W., Lousen T. et al. Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Acta Obstet Gynecol Scand. 2001 Dec;80(12):1096-103. doi: 10.1034/j.1600-0412.2001.801204.x</mixed-citation><mixed-citation xml:lang="en">Jiang Z., Wang Y., Zhao X. et al. Obesity and chronic kidney disease. Am J Physiol Endocrinol Metab. 2023;324(1): E24-E41. doi: 10.1152/ajpendo.00179.2022</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Nørgaard S.K., Vestgaard M.J., Jørgensen I.L. et al. Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes. Diabetes Res Clin Pract. 2018 Apr:138:229-237. doi: 10.1016/j.diabres.2018.02.014</mixed-citation><mixed-citation xml:lang="en">Salvatore S.P., Chevalier J.M., Kuo S.F. et al. Kidney disease in patients with obesity: It is not always obesity-related glomerulopathy alone. Obes Res Clin Pract. 2017;11(5):597-606. doi: 10.1016/j.orcp.2017.04.003</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Демьянова К.А., Козловская Н.Л., Коротчаева Ю.В. и др. Анализ течения и исходов беременности у пациенток с поздними стадиями хронической болезни почек. Тер. Арх. 2021; 93(6): 685-692. doi: 10.26442/00403660.2021.06.200867</mixed-citation><mixed-citation xml:lang="en">Wiles K., Webster P., Seed P.T. et al. The impact of chronic kidney disease Stages 3-5 on pregnancy outcomes. Nephrol Dial Transplant. 2021 Nov 9;36(11):2008-2017. doi: 10.1093/ndt/gfaa247</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Demyanova K.A., Kozlovskaya N.L., Korotchaeva Yu.V. et al. Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease. Ter Arch. 2021; 93(6): 53-59. 685-692. doi: 10.26442/00403660.2021.06.200867</mixed-citation><mixed-citation xml:lang="en">Svetitsky S., Lightstone L., Wiles K. Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study. Obstet Med. 2024 Jun;17(2):96-100. doi: 10.1177/1753495X231201896</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Z., Wang Y., Zhao X. et al. Obesity and chronic kidney disease. Am J Physiol Endocrinol Metab. 2023;324(1): E24-E41. doi: 10.1152/ajpendo.00179.2022</mixed-citation><mixed-citation xml:lang="en">Gussaova S.S., Bobkova I.N., Yashkov Yu.I. et al. Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery. Ter Arch. 2020; 92(6): 53-59. doi: 10.26442/00403660.2020.06.000674</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Salvatore S.P., Chevalier J.M., Kuo S.F. et al. Kidney disease in patients with obesity: It is not always obesity-related glomerulopathy alone. Obes Res Clin Pract. 2017;11(5):597-606. doi: 10.1016/j.orcp.2017.04.003</mixed-citation><mixed-citation xml:lang="en">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024; 105 (Suppl 4S): S117–S314. PMID: 38490803</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wiles K., Webster P., Seed P.T. et al. The impact of chronic kidney disease Stages 3-5 on pregnancy outcomes. Nephrol Dial Transplant. 2021 Nov 9;36(11):2008-2017. doi: 10.1093/ndt/gfaa247</mixed-citation><mixed-citation xml:lang="en">Inzani I., Ozanne S.E. Programming by maternal obesity: a pathway to poor cardiometabolic health in the offspring. Proc Nutr Soc. 2022 Sep;81(3):227-242. doi: 10.1017/S0029665122001914</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Svetitsky S., Lightstone L., Wiles K. Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study. Obstet Med. 2024 Jun;17(2):96-100. doi: 10.1177/1753495X231201896</mixed-citation><mixed-citation xml:lang="en">Svetitsky S., Lightstone L., Wiles K. Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study. Obstet Med. 2024 Jun;17(2):96-100. doi: 10.1177/1753495X231201896</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Гуссаова С.С., Бобкова И.Н., Яшков Ю.И. и др. Изменение метаболических показателей и скорости клубочковой фильтрации у больных морбидным ожирением после бариатрических операций. Тер Архив. 2020; 92(6): 53-59. doi: 10.26442/00403660.2020.06.000674</mixed-citation><mixed-citation xml:lang="en">Гуссаова С.С., Бобкова И.Н., Яшков Ю.И. и др. Изменение метаболических показателей и скорости клубочковой фильтрации у больных морбидным ожирением после бариатрических операций. Тер Архив. 2020; 92(6): 53-59. doi: 10.26442/00403660.2020.06.000674</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gussaova S.S., Bobkova I.N., Yashkov Yu.I. et al. Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery. Ter Arch. 2020; 92(6): 53-59. doi: 10.26442/00403660.2020.06.000674</mixed-citation><mixed-citation xml:lang="en">Gussaova S.S., Bobkova I.N., Yashkov Yu.I. et al. Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery. Ter Arch. 2020; 92(6): 53-59. doi: 10.26442/00403660.2020.06.000674</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024; 105 (Suppl 4S): S117–S314. PMID: 38490803</mixed-citation><mixed-citation xml:lang="en">Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024; 105 (Suppl 4S): S117–S314. PMID: 38490803</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Inzani I., Ozanne S.E. Programming by maternal obesity: a pathway to poor cardiometabolic health in the offspring. Proc Nutr Soc. 2022 Sep;81(3):227-242. doi: 10.1017/S0029665122001914</mixed-citation><mixed-citation xml:lang="en">Inzani I., Ozanne S.E. Programming by maternal obesity: a pathway to poor cardiometabolic health in the offspring. Proc Nutr Soc. 2022 Sep;81(3):227-242. doi: 10.1017/S0029665122001914</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
